# US 2023/0145185 A1 · Cell sorting microbeads as novel contrast agent for magnetic resonance imaging

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0145185 A1
- Document ID: US20230145185A1
- Status: Published application
- Kind: A1
- Application number: 18/054,387
- Filed: 2022-11-10
- Published: 2023-05-11
- Earliest claimed: 2021-11-10
- Assignees: University of Kentucky Research Foundation
- Applicants: University of Kentucky Research Foundation
- Inventors: Fanny Chapelin; Roberto Gedaly; Aman Khurana; Francesc Marti
- Web page: https://patentgrep.com/patent/US20230145185A1

## CPC

- A61K 49/16: Antibodies; Immunoglobulins; Fragments thereof
- A61K 49/1827: {having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle}
- A61K 49/1875: {coated or functionalised with an antibody}
- C12N 5/0006: {Modification of the membrane of cells, e.g. cell decoration}
- C12N 5/0075: {using microcarriers}
- C12N 5/0636: {T lymphocytes}
- C12N 5/0637: {Immunosuppressive T lymphocytes, e.g. regulatory T cells or Treg}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present disclosure generally relates to methods and compositions for obtaining magnetic resonance images of labelled cells. The methods include internalizing a superparamagentic iron oxide nanoparticle within a desired population of cells and then observing the cells through the contrast provided in magnetic resonance imaging. The methods are applicable for in vivo use to monitor desired cells types.

## Claims

### Claim 1

A method for obtaining a magnetic resonance image (MRI) of a cell, comprising:
obtaining a cellular sample and binding to one or more cells therein a nanoparticle comprised of an antibody or active fragment thereof to a cell surface protein covalently linked to at least one superparamagnetic iron oxide nanoparticle;
incubating the one or more cells for a period of time from about 5 minutes to 24 hours or more and/or stimulating the one or more cells with an agonist to cause the nanoparticle to be internalized; and,
obtaining at least one MRI of the one or more cells.

### Claim 2 (depends on 1)

The method of claim 1, wherein the cellular sample is obtained from a subject.

### Claim 3 (depends on 2)

The method of claim 2, further comprising administering the one or more cells back to the subject prior to obtaining the at least one MRI.

### Claim 4 (depends on 1)

The method of claim 1, further comprising administering the one or more cells to a subject prior to obtaining the at least one MRI.

### Claim 5 (depends on 1)

The method of claim 1, further comprising isolating the one or more cells from the cellular sample.

### Claim 6 (depends on 1)

The method of claim 1, wherein the antibody or active fragment thereof binds to CD25.

### Claim 7 (depends on 6)

The method of claim 6, wherein the antibody or active fragment thereof binds to human CD25.

### Claim 8 (depends on 6)

The method of claim 6, wherein the agonist is CD3, CD28, IL-2, or a combination thereof.

### Claim 9 (depends on 1)

The method of claim 1, wherein the antibody or active fragment thereof binds to CD4.

### Claim 10 (depends on 9)

The method of claim 9, wherein the antibody or active fragment thereof binds to human CD4.

### Claim 11 (depends on 9)

The method of claim 9, wherein the agonist is CD3, CD28, IL-2, or a combination thereof.

### Claim 12 (depends on 1)

The method of claim 1, wherein incubating comprises providing a cellular medium and about 37° C. temperature to the one or more cells.

### Claim 13 (depends on 1)

The method of claim 1, wherein the one or more cells are T cells.

### Claim 14 (depends on 13)

The method of claim 13, wherein the T cells are Treg cells.

### Claim 15 (depends on 1)

The method of claim 1, wherein the agonist is covalently linked to a solid support.

### Claim 16 (depends on 15)

The method of claim 15, wherein the solid support is a microparticle.

### Claim 17

A nanoparticle for MRI comprised of a superparamagnetic iron oxide nanoparticle covalently linked to an antibody or active fragment thereof, wherein the antibody or active fragment thereof recognizes a cell surface protein.
